Best Practices for the Management of Thromboembolism
Paul Ament, PharmD, reviews the guidelines for the treatment of VTE.
Paul Ament, PharmD, reviews the data from studies looking into the prevention of VTEs and Riley Bowers, PharmD, shares the real-world data to the studies.
A panel of experts discuss the risks vs benefits of prophylactic care for patients to prevent VTE.
Experts in the management of VTE discuss the deterrents among providers, patients, and pharmacists, specifically looking at the various dosage forms of treatment.
Panelists review the challenges in managing VTE.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Cholesterol-HDL-Glucose Index Linked to Type 2 Diabetes Prevalence in Adults
4
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
5
